Pharmaceutical formulations comprising 1-(beta-D-glucopyranosyl)-2 -thienylmethylbenzene derivatives as inhibitors of SGLT

Pharmaceutical formulations comprising 1-(beta-D-glucopyranosyl)-2 -thienylmethylbenzene derivatives as inhibitors of SGLT

  • CN 102,883,726 A
  • Filed: 05/11/2011
  • Published: 01/16/2013
  • Est. Priority Date: 05/11/2010
  • Status: Active Application
First Claim
Patent Images

1. One kind can be Orally administered pharmaceutical preparation, described pharmaceutical preparation comprises:

  • (a) chemical compound of formula (I) or its prodrug or pharmaceutically acceptable salt

View all claims
    ×
    ×

    Thank you for your feedback

    ×
    ×